Young Jonathan sold AKRO
September 2, 2025 · Form 4 insider transaction
Young Jonathan sold 61 shares of Akero Therapeutics, Inc. at $47.58 per share, a transaction worth $2.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
61
Price
$47.58
Total value
$2.9K
InsiderYoung Jonathan
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 2, 2025
Filing dateSeptember 4, 2025
Shares owned after197,484
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated April 29, 2025, previously adopted by the Reporting Person.